Statement Of Financial Position [Abstract]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
44,748 GBP
50,152 GBP
Cash and cash equivalents
337,112 GBP
537,322 GBP
2,322,974 GBP
Assets
5,750,745 GBP
6,088,568 GBP
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
1,357,366 GBP
1,291,500 GBP
Retained earnings
5,265,071 GBP
4,293,268 GBP
Share premium
4,619,793 GBP
4,403,094 GBP
Equity
5,265,071 GBP
4,619,793 GBP
1,357,366 GBP
69,931 GBP
3,700,000 GBP
407,000 GBP
4,889,019 GBP
5,499,543 GBP
4,293,268 GBP
4,403,094 GBP
1,291,500 GBP
12,680 GBP
3,700,000 GBP
385,537 GBP
7,206,636 GBP
4,403,094 GBP
375,135 GBP
2,548,728 GBP
1,291,500 GBP
14,365 GBP
3,700,000 GBP
Liabilities [abstract]
Deferred tax liabilities
281,911 GBP
281,911 GBP
Liabilities
861,726 GBP
589,025 GBP
Equity and liabilities
5,750,745 GBP
6,088,568 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.